Chugai Pharmabody Research
CHRISTIAN WIRAJA is a Senior Scientist II at Chugai Pharmabody Research with extensive experience in the development of micro/nanotechnology for organoid and transdermal diagnosis and drug delivery. CHRISTIAN previously held positions at Nanyang Technological University as a Postdoctoral Research Fellow and at Harvard Medical School as an Exchange Research Scholar. CHRISTIAN also worked as a Product and Innovation Designer at the Singapore Institute of Manufacturing Technology, where CHRISTIAN contributed to the development of medical devices utilizing microfluidic technologies. CHRISTIAN WIRAJA holds a PhD in Bioengineering and Biomedical Engineering and a Bachelor's degree in the same field from Nanyang Technological University.
This person is not in any offices
Chugai Pharmabody Research
1 followers
In the global medical field, there are many diseases in which there are no drug or current drugs are insufficient to address the medical needs of patients. Chugai Pharmabody Research (CPR) is a subsidiary company of Chugai Pharmaceutical in Japan, a member of Roche group, and is committed to address these unmet needs by specializing in the field of antibody drug discovery utilizing proprietary antibody engineering technologies.